ALNY vs MLSS · P/E 76, rev $1.29B vs rev $5.0M
Alnylam Pharmaceuticals Inc (ALNY) versus Milestone Scientific (MLSS) — a side-by-side from cached financials, not a winner call.
Alnylam Pharmaceuticals Inc (ALNY) is a biotechnology company listed on US.
Milestone Scientific (MLSS) is a medical instruments & supplies company listed on US.
Latest reported ALNY revenue for 2026-06-30 was $1.29B. Net income was $164.5M. Revenue was up 3.4% from 2025-09-30 to 2026-06-30. ALNY currently screens at market cap $40.46B and trailing P/E 76.3.
Latest reported MLSS revenue for 2026-06-30 was $5.0M. Net income was -$1.9M. MLSS currently screens at market cap $29.9M.
ALNY currently screens at market cap $40.46B and trailing P/E 76.3. MLSS currently screens at market cap $29.9M.
Not investment advice. Open the ALNY and MLSS stock pages for the full models.
Not investment advice.